Farmepo sp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-05-23
Share capital
30,000.00 PLN
Activity description

Farmepo manages a nationwide network of 15 clinical research sites with 100 active investigators and 10 years of experience from 400 completed clinical trials. It supports pharmaceutical companies and CROs, medical facilities, physicians, and healthcare staff, coordinating projects from site identification through study delivery. Its therapeutic areas include cardiology, diabetology, neurology and psychiatry, dermatology, endocrinology, pulmonology, oncology, and metabolic diseases.

Registered address
ul. Gdańska 32/8, 85-006 Bydgoszcz, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-88034-30517-ARCBI-28

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 30 days early.

  • 202512/05/2026
  • 202403/07/2025
  • 202301/07/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Human health activities72 / 2,917
Top 2.5%
Top 2.5%
City · Bydgoszcz293 / 3,099
Top 9.4%
Voivodeship · Kujawsko-Pomorskie1,341 / 11,462
Top 12%
Country · Poland31,900 / 298,026
Top 11%

Results vs industry

Revenue
This companyUSD 5.30mMedianUSD 92.12kAverageUSD 1.32m
Net profit
This companyUSD 1.60mMedianUSD 2.68kAverageUSD 141.01k
Operating costs
This companyUSD 3.36mMedianUSD 82.77kAverageUSD 1.13m
Assets
This companyUSD 731.71kMedianUSD 38.83kAverageUSD 922.68k

Offer

  • Conduct of clinical trials
  • Clinical trial organisation
  • Support for medical centers
  • Cooperation with pharmaceutical companies
  • Cooperation with researchers

Websites

  • farmepo.comSieć ośrodków badań klinicznych w Polsce | Farmepo
    Google AnalyticsGoogle Tag ManagerLiteSpeed

Authorized Representatives

Błażej Bujanowski age 39 – Attorney-in-fact (sole)
Michał Wiśniewski age 43 – President of the Management Board
Paweł Rudowski age 39 – Vice President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
49$3,970.8349%
51$4,132.9051%

Beneficial owners

Person

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2024-11-01.

  • mBank
    36 1140 2004 0000 3412 1925 6733
  • mBank
    06 1140 2004 0000 3702 8371 7152
  • mBank
    42 1140 2004 0000 3502 8619 6407

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Pratia S.A.
Kapadi sp. z o.o.
Humaneva S.A.
Penta Hospitals Badania Kliniczne sp. z o.o.
Brillance sp. z o.o.
Clinchoice sp. z o.o.
Neuca Clinical Trials Investments sp. z o.o.
Associated Medical Clinical Science Services sp. z o.o.
2kmm sp. z o.o.
Scientia Cro sp. z o.o.

FAQ

Last updated: 2026-05-12